Study partners should be required in preclinical Alzheimer’s disease trials
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Study partners should be required in preclinical Alzheimer’s disease trials
Authors
Keywords
Preclinical Alzheimer’s disease, Informant, Clinical trial, Biomarker, Study partner
Journal
Alzheimers Research & Therapy
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-06
DOI
10.1186/s13195-017-0327-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
- (2017) Jing Qian et al. PLOS MEDICINE
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability
- (2016) Yen Ying Lim et al. Alzheimers & Dementia
- Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials
- (2016) Joshua D. Grill et al. NEUROBIOLOGY OF AGING
- Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study
- (2016) Meera Sheffrin et al. Alzheimers Research & Therapy
- Unfinished Business in Preventing Alzheimer Disease
- (2016) Jason Karlawish et al. JAMA Internal Medicine
- Errors in Self-Reports of Health Services Use
- (2015) Christopher M. Callahan et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Predictive Testing for Alzheimer’s Disease
- (2015) Richard J. Caselli et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials
- (2015) S. Y. H. Kim et al. NEUROLOGY
- Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials
- (2015) R. B. Postuma et al. NEUROLOGY
- Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
- (2015) Kristin Harkins et al. Alzheimers Research & Therapy
- Tracking Early Decline in Cognitive Function in Older Individuals at Risk for Alzheimer Disease Dementia
- (2015) Rebecca E. Amariglio et al. JAMA Neurology
- An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
- (2014) Jessica B. Langbaum et al. Alzheimers & Dementia
- Public Perceptions of Presymptomatic Testing for Alzheimer Disease
- (2014) Richard J. Caselli et al. MAYO CLINIC PROCEEDINGS
- Confidentiality in preclinical Alzheimer disease studies: When research and medical records meet
- (2014) J. J. Arias et al. NEUROLOGY
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults
- (2013) Katherine A. Gifford et al. Alzheimers & Dementia
- Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease
- (2013) Nicholas Kozauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicting positivity for a new era of Alzheimer disease prevention trials
- (2012) J. M. Burns et al. NEUROLOGY
- Effect of study partner on the conduct of Alzheimer disease clinical trials
- (2012) J. D. Grill et al. NEUROLOGY
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Damage Prevention and Control for Financial Incapacity
- (2011) Charles P. Sabatino JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
- (2011) J. Karlawish NEUROLOGY
- NIA-Funded Alzheimer Centers Are More Efficient than Commercial Clinical Recruitment Sites for Conducting Secondary Prevention Trials of Dementia
- (2010) Steven D. Edland et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Quality of Life of Patients with Alzheimer’s Disease: Differential Perceptions between Spouse and Adult Child Caregivers
- (2010) J.L. Conde-Sala et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study
- (2010) Sato Ashida et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Disclosure ofAPOEGenotype for Risk of Alzheimer's Disease
- (2009) Robert C. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Views of Alzheimer Disease Patients and Their Study Partners on Proxy Consent for Clinical Trial Enrollment
- (2008) Jason Karlawish et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Clinical Trial Design Issues in Mild to Moderate Alzheimer Disease
- (2008) David S. Knopman Cognitive and Behavioral Neurology
- Chronic disease long-term drug prevention trials: Lessons from the Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT)
- (2007) Curtis L. Meinert et al. Alzheimers & Dementia
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search